Commonwealth Equity Services
EVFM

Commonwealth Equity Services’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

Commonwealth Equity Services’s Portfolio EVFM Stock Details EVFM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-11,437
Closed -$12K – 3821
2022
Q2 		$12K Buy
11,437
+9,696
+557% +$16K ﹤0.01% 3614
2022
Q1 		$8K Sell
1,741
-1,283
-42% -$8.07K ﹤0.01% 3691
2021
Q4 		$17K Sell
3,024
-1,679
-36% -$14.3K ﹤0.01% 3614
2021
Q3 		$52K Sell
4,703
-1,381
-23% -$17.4K ﹤0.01% 3498
2021
Q2 		$103K Buy
6,084
+3,604
+145% +$68.3K ﹤0.01% 3397
2021
Q1 		$65K Sell
2,480
-1,650
-40% -$75K ﹤0.01% 3319
2020
Q4 		$149K Buy
4,130
+1,103
+36% +$39.9K ﹤0.01% 2991
2020
Q3 		$107K Buy
+3,027
New +$132K ﹤0.01% 2870

Other funds holding EVFM

CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return
LTI
Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return

Commonwealth Equity Services's EVFM Position: Q3 2022 in Review

Commonwealth Equity Services sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q3 2022, closing a stake of 11,437 shares — an estimated $12K sold.

Commonwealth Equity Services first reported a position in EVFM in Q3 2020 and held it in 8 quarters. The position peaked at $149K in Q4 2020. 8 funds tracked by Wall St. Rank hold EVFM as of Q3 2022.

  • Commonwealth Equity Services reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Commonwealth Equity Services sold 11,437 Evofem Biosciences, Inc. Common Stock shares in Q3 2022, an estimated $12K.
  • Commonwealth Equity Services first reported a position in Evofem Biosciences, Inc. Common Stock in Q3 2020 and held it in 8 quarters.
  • Commonwealth Equity Services's Evofem Biosciences, Inc. Common Stock position peaked at $149K in Q4 2020.
  • 8 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q3 2022.

Based on Commonwealth Equity Services's 13F filing for Q3 2022, filed 14 Nov 2022.